Eras
InSightec’s ExAblate® 2000 MR-guided focused ultrasound system was cleared for the non-invasive treatment of symptomatic uterine fibroids by the U.S. Food & Drug Administration.
InSightec’s ExAblate® 2000 MR-guided focused ultrasound system was cleared for the non-invasive treatment of symptomatic uterine fibroids by the U.S. Food & Drug Administration.